Accelovance — Huntsville, Alabama

Accelovance is a clinical research site located in Huntsville, Alabama, United States 35802.

Crixeo Clinical Trials Trust Score: 17/100 (FAILING). This profile has not yet been claimed by the site owner.

Accelovance has participated in 7 clinical trials.

Therapeutic areas: Influenza, Meningitis, Meningococcal, Meningococcal Disease.

Sponsors: Alachua Government Services, Inc., Pfizer, Novartis Vaccines.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Huntsville

Browse all research sites in Alabama · View every site in Huntsville

• Huntsville Hospital - The Heart Center, PC
• Heart Center Research/Huntsville Hospital
• University of Alabama at Birmingham Huntsville Regional Medical Campus
• Hunstville Hospital
• University of Alabama - Huntsville Regional Medical Campus /ID# 267818
• Oakwood University
• Huntsville Hospital Heart Center
• University of Alabama in Huntsville
• Huntsville Hospital System
• University of Alabama at Birmingham-Huntsville
• Heart Center Hospital
• University of Alabama at Birmingham

Sponsor Feasibility Report

Trust Score: 17/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Accelovance?

Accelovance has a Crixeo Trust Score of 17/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Accelovance conducted?

Accelovance has 7 clinical trials on record. Their work covers Influenza, Meningitis, Meningococcal, Meningococcal Disease.

Is Accelovance accredited by Crixeo Clinical Trials?

Accelovance has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Accelovance?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.